Cannabis Brands Face Major Lawsuit Over Product Mislabeling

Industry News - Major Lawsuit

Cannabis companies including Aurora Cannabis, Cronos, and Tilray are (potentially) facing a serious class-action lawsuit. The cause of this: a statement filed in Calgary accusing the companies of falsely advertising the potency of their products

More precisely, the plaintiffs are claiming that these cannabis companies are displaying negligence on their behalf and are failing to correctly label their products. A $500-million judgment is expected by the plaintiffs, as well as punitive damages of another $5 million from each of the companies. 

Cannabis companies, including the three we just mentioned, have not yet publicly commented on the matter regarding these serious allegations.

The claim was filed by Lisa Marie Langevin, who purchased a cannabis oil product from Tilray in Calgary. After not feeling the intended effects of the product on a couple of occasions, her colleague with a Ph.D. in biochemistry, Shaun Mesher, sent the Tilray item to a lab to analyze the potency. The results were shocking.

The tests revealed that the cannabis oil contained merely 46% of the supposed Tetrahydrocannabinol (THC) content. Furthermore, according to the claim, another product from the same lot had only 79% of what the company had advertised.

After finding this out, Mesher also tested several other products from different brands. In total, the claim referred to six different samples that contained varying THC levels than what the package of the product displayed. Two of these products were stronger, whereas the others were weaker than advertised

In fact, the content of THC ranged from 54% to up to 119% of the value displayed on the label. What’s more, none of these products have been subjected to recalls from Health Canada.

According to the lawyer who represents the plaintiff, John Kingman Phillips, if a product contains either more or less of the psychoactive substance than what the label displays, there’s danger involved. In fact, if the labeling is done incorrectly, a buyer may end up overdosing. Additionally, the buyer’s not getting what they paid for.

For the lawsuit to proceed as a class action, it would need to be certified at the Court of Queen’s Bench in Alberta by a judge. According to Phillips, the legal action may cast light on the potential quality control issues in the cannabis industry.

Leave a Comment

Your email address will not be published. *